Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes reached their optimal basal insulin dose in 15 days with use of an artificial ...
Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors. The company said its Smart Basal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results